Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Analysis of the Changes in the Sarcoma Tumor Immune Microenvironment Following Trabectedin

NCT03397186 is registered in ClinicalTrials.gov with Fred Hutchinson Cancer Center as lead sponsor.

NCT NCT03397186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03397186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Analysis of the Changes in the Sarcoma Tumor Immune Microenvironment Following Trabectedin
Lead sponsor
Fred Hutchinson Cancer Center
Phase
Phase 2
Overall status
Withdrawn
Start date
June 19, 2018
Completion date
May 1, 2021
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic soft tissue sarcoma, myxoid liposarcoma, round cell liposarcoma, stage iii soft tissue sarcoma ajcc v7, stage iv soft tissue sarcoma ajcc v7, unresectable soft tissue sarcoma